Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.	Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder, hypoplastic left heart syndrome	Active, not recruiting	Phase 2	2025-06-25		NCT04925024

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ann & Robert H Lurie Children's Hospital of Chicago	76
Longeveron Inc.	1
National Heart, Lung, and Blood Institute (NHLBI)	791
The University of Texas Health Science Center, Houston	261

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Advocate Children's Hospital	Chicago	United States	1
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Boston Children's Hospital	Boston	United States	343
Children's Healthcare of Atlanta	Atlanta	United States	47
Children's Hospital Colorado	Aurora	United States	312
Children's Hospital of Los Angeles	Los Angeles	United States	56
Children's Hospital of Philadelphia	Philadelphia	United States	434
Children's Nebraska	Omaha	United States	9
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Primary Children's Hospital/University of Utah	Salt Lake City	United States	2